Rachel McMinn, CEO: Neurogene NGNE Buy · Filed 24/11/25

Trade details

Type: Insider buy
Amount: $969,000
Shares · price: 47,500 sh · $20.40 a share
Held after: 1,297,859 sh
Stock: Neurogene NGNE
Person: Rachel McMinnCEO
Trade date: 24/11/22
Filed: 24/11/25
Days to filing: 3 days

First buy since 2023

Insiders buying this week: 5 insiders
Holding change: +3.8%

Neurogene trades, last 26 weeks

What else happened in Neurogene around then

Filed or reported within 30 days of the trade day · 24/10/23~24/12/22

Rachel McMinn's recent trades

Rachel McMinnCEO
Sell10b5-1 planNeurogene
Sell10b5-1 plan
Neurogene
NGNE
$74K
3,352 sh
$74K
Filed 03/30
Traded 03/26